Literature DB >> 26220059

Trends in Utilization of Vocal Fold Injection Procedures.

David E Rosow1.   

Abstract

Office-based vocal fold injections have become increasingly popular over the past 15 years. Examination of trends in procedure coding for vocal fold injections in the United States from 2000 to 2012 was undertaken to see if they reflect this shift. The US Part B Medicare claims database was queried from 2000 through 2012 for multiple Current Procedural Terminology codes. Over the period studied, the number of nonoperative laryngoscopic injections (31513, 31570) and operative medialization laryngoplasties (31588) remained constant. Operative vocal fold injection (31571) demonstrated marked linear growth over the 12-year study period, from 744 procedures in 2000 to 4788 in 2012-an increase >640%. The dramatic increased incidence in the use of code 31571 reflects an increasing share of vocal fold injections being performed in the operating room and not in an office setting, running counter to the prevailing trend toward awake, office-based injection procedures. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2015.

Keywords:  laryngology; procedure coding; vocal fold injections

Mesh:

Year:  2015        PMID: 26220059     DOI: 10.1177/0194599815597208

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

1.  The safety of in-office laryngologic procedures during active antithrombotic therapy.

Authors:  Jeffrey M Straub; Kevin A Calamari; Timothy J Shin; Sarah A Janse; Lowell A Forrest; Brad W deSilva; Laura A Matrka
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-09-02

2.  Real-Time Light-Guided Vocal Fold Injection via the Cricothyroid Membrane in Unilateral Vocal Fold Paralysis: A Human Pilot Study.

Authors:  Gene Huh; Pil Geun Jang; Seung Hoon Han; Ramla Talib Mohammad; Woo Jin Jeong; Wonjae Cha
Journal:  Clin Exp Otorhinolaryngol       Date:  2022-04-08       Impact factor: 3.340

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.